NJIT News Room

Looking for something?
Search Newsroom
RSS Feed
PRESS RELEASE
Contact Information: Tanya Klein Public Relations 973-596-3433

Urovalve's CEO Dr. Harvey Homan Appointed to NIH Center for Scientific Review

Urovalve, a medical device company located in the NJIT Enterprise Development Center, has announced that President and CEO Harvey Homan PhD has been appointed to an advisory panel for urology and small business at the Center for Scientific Review (CSR) a division of the National Institutes of Health (NIH).  Urovalve, a privately-held company, develops superior medical devices to address problems associated with urinary flow and control

The CSR evaluates the majority (70 percent) of the research grant applications sent to NIH.

“I am extremely proud to be appointed to serve the Center for Scientific Research,” said Homan. “CSR’s mission is to help NIH identify the most promising research for treating, curing and preventing disease, and I am certainly honored to serve that noble purpose.”

In fiscal year 2009, CSR reviewed 71,000 applications. Members of the CSR’s Urology Clinical and Small Business panel include distinguished professionals from Wake Forest School of Medicine, Stanford University School of Medicine, Children’s Hospital Boston, Baylor College of Medicine, Cleveland Clinic Foundation, Albert Einstein College of Medicine, University of Southern California, University of Pittsburgh and University of Chicago, among other eminent healthcare institutions.

Urovalve™, Inc. has developed and patented technology to control fluid flow through small diameter flexible tubing. The core proprietary technology for the Surinate® bladder management system is comprised of a simple magnetically controlled valve that can be activated remotely by a Surinate® wearer who uses a hand-held magnet to self-regulate flow. Currently available devices require continuous bladder drainage or insertion of a tube into the urethra several times each day.

The Enterprise Development Center at NJIT is New Jersey’s oldest and largest high-technology business incubator. The EDC gives early-stage start-ups an edge in meeting the many challenges of commercialization. Among the companies housed at the EDC are firms building marketplace success with breakthrough work in areas such as video e-learning, renewable energy, products in the life sciences for medical diagnosis and therapy, information technology, telecommunications and advanced materials.

One of the nation's leading public technological universities, New Jersey Institute of Technology (NJIT) is a top-tier research university that prepares students to become leaders in the technology-dependent economy of the 21st century. NJIT's multidisciplinary curriculum and computing-intensive approach to education provide technological proficiency, business acumen and leadership skills. With an enrollment of more than 10,000 graduate and undergraduate students, NJIT offers small-campus intimacy with the resources of a major public research university. NJIT is a global leader in such fields as solar research, nanotechnology, resilient design, tissue engineering, and cyber-security, in addition to others. NJIT ranks 5th among U.S. polytechnic universities in research expenditures, topping $110 million, and is among the top 1 percent of public colleges and universities in return on educational investment, according to PayScale.com.